简体中文 | 繁體中文 | English

Products & Services News

2018-07-25 09:57 IBC2018 Enhances Conference Programme with Keynote Sessions from Amazon, Viacom and Wonderhood Studios
2018-07-25 09:54 Toshiba Releases Compact Power MOSFET Gate Driver Intelligent Power Device
2018-07-24 17:52 OAG Partners with Plug and Play to Help Travel Startups Grow, Innovate and Disrupt
2018-07-24 17:48 Toshiba Memory Corporation Unveils Industry's First SSDs Utilizing 96-Layer, 3D Flash Memory
2018-07-24 13:00 Gemalto Helps Companies Gain Valuable Data Insights, Reduce Cost and Time with Automatic Software Updates
2018-07-24 10:00 FDA Clears First Nanotechnology Peek Devices for Spinal Intervertebral Fusion
2018-07-24 09:49 Darigold Expands Global Operations
2018-07-23 19:07 Ferring’s Heat-Stable Carbetocin Could Save Thousands of Women’s Lives by Preventing Excessive Bleeding after Childbirth
2018-07-23 09:38 GlobalPlatform Expands Annual Seminar in China
2018-07-20 18:22 Toshiba Memory Corporation Develops 96-layer BiCS FLASH™ with QLC Technology
2018-07-20 18:20 FlipNpik Opens Its Private Sale to Public and Introduces Fiat-Based Payment Gateway
2018-07-20 15:00 UAE’s $8 Billion Tech Industry Presents Extensive Growth Opportunities for Chinese Businesses
2018-07-20 13:10 The Poseidon Foundation: Liverpool Bids to Be First ‘Climate Positive’ City by End of 2020
2018-07-20 13:05 Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease
2018-07-20 09:20 Seoul Semiconductor Delivers Its Innovative LED "SunLike" to U.S. Lighting Market
2018-07-20 09:16 Boehringer Ingelheim and Lilly announce Trajenta®’s CARMELINA® cardiovascular outcome trial met its primary endpoint
2018-07-19 18:33 Tigo Releases State-of-the-art Wireless Technology – Mesh – as the New Solar Communication Architecture for the TS4 Platform
2018-07-19 14:50 Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials
2018-07-19 13:59 22nd Century Announces the Immediate Feasibility of the FDA’s Nicotine Reduction Plan
2018-07-19 13:51 New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

Business Wire Weibo

Press Releases

Latest Releases